Guthart Gary S - Jul 28, 2025 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Role
Executive Chair of the Board o, Director
Signature
By: Stephanie Lim-Ignacio For: Guthart, Gary S
Stock symbol
ISRG
Transactions as of
Jul 28, 2025
Transactions value $
-$4,853,084
Form type
4
Date filed
7/29/2025, 01:02 PM
Previous filing
May 23, 2025
Next filing
Sep 2, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
GUTHART GARY S Executive Chair of the Board o, Director 1020 KIFER ROAD, SUNNYVALE By: Stephanie Lim-Ignacio For: Guthart, Gary S 2025-07-29 0001280628

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISRG Common Stock Options Exercise $469K +7.89K +59.85% $59.46 21.1K Jul 28, 2025 Direct F1
transaction ISRG Common Stock Sale -$3.94M -7.89K -37.44% $498.64 13.2K Jul 28, 2025 Direct F1, F2
transaction ISRG Common Stock Sale -$693K -1.4K -7.03% $495.23 18.5K Jul 28, 2025 Trust FBO Daughter F1, F3
transaction ISRG Common Stock Sale -$693K -1.4K -7.03% $495.24 18.5K Jul 28, 2025 Trust FBO Son F1, F4
transaction ISRG Common Stock Gift $0 -10.5K -0.86% $0.00 1.2M Jul 28, 2025 by Trust F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -7.89K -100% $0.00 0 Jul 28, 2025 Common Stock 7.89K $59.46 Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on April 28, 2026.
F2 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $494.33 to $500.00 as follows: 475 shares sold at $494.33 to $495.16; 202 shares sold at $495.79 to $496.62; 1,045 shares sold at $496.81 to $496.87; 1,996 shares sold at $498.06 to $499.00; and 4,175 shares sold at $499.20 to $500.00. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $493.85 to $496.31 as follows: 527 shares sold at $493.85 to $494.81; 569 shares sold at $494.97 to $495.72; and 304 shares sold at $496.00 to $496.31. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F4 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $493.85 to $496.31 as follows: 320 shares sold at $493.85 to $494.85; 806 shares sold at $494.87 to $495.62; and 274 shares sold at $496.00 to $496.31. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F5 The shares were donated to a Donor Advised Fund (DAF) in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on April 28, 2026.
F6 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.